title: Asymptomatic hyperamylasemia and hyperlipasemia associated with aripiprazole.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Lattanzi
authors.forename: Francesco
authors.initials: F
authors.lastname: Casamassima
authors.forename: Maurizia
authors.initials: M
authors.lastname: Brunetto
authors.forename: Alessandro
authors.initials: A
authors.lastname: Tatulli
authors.forename: Antonio
authors.initials: A
authors.lastname: Longobardi
authors.forename: Elisa
authors.initials: E
authors.lastname: Schiavi
authors.forename: Alessandra
authors.initials: A
authors.lastname: Danese
authors.forename: Antonella
authors.initials: A
authors.lastname: Litta
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Stange
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Cassano
mesh_terms: D000328:Adult; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D034321:Hyperamylasemia / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D008049:Lipase / Q000097:blood*; D010195:Pancreatitis / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis; D010879:Piperazines / Q000009:adverse effects*; D015363:Quinolones / Q000009:adverse effects*
chemical_list: D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D008049:Lipase